Global Next Generation Cancer Diagnostics Market Research Report 2021
- Published Date: 2021-04-20
- Report ID: 101485
- Pages: 180
-
Format:
Prudent Markets Predicts that Next Generation Cancer Diagnostics Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Next Generation Cancer Diagnostics Market Overview:
Global Next Generation Cancer Diagnostics Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Next Generation Cancer Diagnostics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Next Generation Cancer Diagnostics Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Next Generation Cancer Diagnostics market in 2020.
Global Next Generation Cancer Diagnostics Market Segmentation
By Type, Next Generation Cancer Diagnostics market has been segmented into:
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
By Application, Next Generation Cancer Diagnostics market has been segmented into:
Hospitals
Clinics
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Next Generation Cancer Diagnostics market are:
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
1. Market Overview of Next Generation Cancer Diagnostics
1.1 Next Generation Cancer Diagnostics Market Overview
1.1.1 Next Generation Cancer Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Next Generation Cancer Diagnostics Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Next Generation Cancer Diagnostics Historic Market Size by Regions (2015-2020)
1.4 Next Generation Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Next Generation Cancer Diagnostics Sales Market by Type (2015-2026)
2.1 Global Next Generation Cancer Diagnostics Historic Market Size by Type (2015-2020)
2.2 Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2021-2026)
2.3 Next Generation Sequencing
2.4 qPCR & Multiplexing
2.5 DNA Microarrays
2.6 Others
3. Covid-19 Impact Next Generation Cancer Diagnostics Sales Market by Application (2015-2026)
3.1 Global Next Generation Cancer Diagnostics Historic Market Size by Application (2015-2020)
3.2 Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2021-2026)
3.3 Hospitals
3.4 Clinics
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Next Generation Cancer Diagnostics Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Next Generation Cancer Diagnostics Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Next Generation Cancer Diagnostics Business
5.1 Cepheid
5.1.1 Cepheid Company Profile
5.1.2 Cepheid Next Generation Cancer Diagnostics Product Specification
5.1.3 Cepheid Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Koninklijke Philips N.V
5.2.1 Koninklijke Philips N.V Company Profile
5.2.2 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Specification
5.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 F. Hoffmann-La Roche Ltd
5.3.1 F. Hoffmann-La Roche Ltd Company Profile
5.3.2 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Specification
5.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Qiagen
5.4.1 Qiagen Company Profile
5.4.2 Qiagen Next Generation Cancer Diagnostics Product Specification
5.4.3 Qiagen Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Novartis AG
5.5.1 Novartis AG Company Profile
5.5.2 Novartis AG Next Generation Cancer Diagnostics Product Specification
5.5.3 Novartis AG Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Abbott
5.6.1 Abbott Company Profile
5.6.2 Abbott Next Generation Cancer Diagnostics Product Specification
5.6.3 Abbott Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Thermo Fisher Scientific
5.7.1 Thermo Fisher Scientific Company Profile
5.7.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Specification
5.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Opko Health
5.8.1 Opko Health Company Profile
5.8.2 Opko Health Next Generation Cancer Diagnostics Product Specification
5.8.3 Opko Health Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Myriad Genetics
5.9.1 Myriad Genetics Company Profile
5.9.2 Myriad Genetics Next Generation Cancer Diagnostics Product Specification
5.9.3 Myriad Genetics Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Agilent Technologies
5.10.1 Agilent Technologies Company Profile
5.10.2 Agilent Technologies Next Generation Cancer Diagnostics Product Specification
5.10.3 Agilent Technologies Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 GE Healthcare
5.11.1 GE Healthcare Company Profile
5.11.2 GE Healthcare Next Generation Cancer Diagnostics Product Specification
5.11.3 GE Healthcare Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 PerkinElmer
5.12.1 PerkinElmer Company Profile
5.12.2 PerkinElmer Next Generation Cancer Diagnostics Product Specification
5.12.3 PerkinElmer Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Genomic Health
5.13.1 Genomic Health Company Profile
5.13.2 Genomic Health Next Generation Cancer Diagnostics Product Specification
5.13.3 Genomic Health Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Illumina
5.14.1 Illumina Company Profile
5.14.2 Illumina Next Generation Cancer Diagnostics Product Specification
5.14.3 Illumina Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Hologic
5.15.1 Hologic Company Profile
5.15.2 Hologic Next Generation Cancer Diagnostics Product Specification
5.15.3 Hologic Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Almac Group
5.16.1 Almac Group Company Profile
5.16.2 Almac Group Next Generation Cancer Diagnostics Product Specification
5.16.3 Almac Group Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Janssen Global Services
5.17.1 Janssen Global Services Company Profile
5.17.2 Janssen Global Services Next Generation Cancer Diagnostics Product Specification
5.17.3 Janssen Global Services Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 Sysmex Corporation
5.18.1 Sysmex Corporation Company Profile
5.18.2 Sysmex Corporation Next Generation Cancer Diagnostics Product Specification
5.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Next Generation Cancer Diagnostics Market Size (2015-2026)
6.2 North America Next Generation Cancer Diagnostics Key Players in North America (2015-2020)
6.3 North America Next Generation Cancer Diagnostics Market Size by Type (2015-2020)
6.4 North America Next Generation Cancer Diagnostics Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Next Generation Cancer Diagnostics Market Size (2015-2026)
7.2 East Asia Next Generation Cancer Diagnostics Key Players in North America (2015-2020)
7.3 East Asia Next Generation Cancer Diagnostics Market Size by Type (2015-2020)
7.4 East Asia Next Generation Cancer Diagnostics Market Size by Application (2015-2020)
8. Europe
8.1 Europe Next Generation Cancer Diagnostics Market Size (2015-2026)
8.2 Europe Next Generation Cancer Diagnostics Key Players in North America (2015-2020)
8.3 Europe Next Generation Cancer Diagnostics Market Size by Type (2015-2020)
8.4 Europe Next Generation Cancer Diagnostics Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Next Generation Cancer Diagnostics Market Size (2015-2026)
9.2 South Asia Next Generation Cancer Diagnostics Key Players in North America (2015-2020)
9.3 South Asia Next Generation Cancer Diagnostics Market Size by Type (2015-2020)
9.4 South Asia Next Generation Cancer Diagnostics Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Next Generation Cancer Diagnostics Market Size (2015-2026)
10.2 Southeast Asia Next Generation Cancer Diagnostics Key Players in North America (2015-2020)
10.3 Southeast Asia Next Generation Cancer Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Next Generation Cancer Diagnostics Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Next Generation Cancer Diagnostics Market Size (2015-2026)
11.2 Middle East Next Generation Cancer Diagnostics Key Players in North America (2015-2020)
11.3 Middle East Next Generation Cancer Diagnostics Market Size by Type (2015-2020)
11.4 Middle East Next Generation Cancer Diagnostics Market Size by Application (2015-2020)
12. Africa
12.1 Africa Next Generation Cancer Diagnostics Market Size (2015-2026)
12.2 Africa Next Generation Cancer Diagnostics Key Players in North America (2015-2020)
12.3 Africa Next Generation Cancer Diagnostics Market Size by Type (2015-2020)
12.4 Africa Next Generation Cancer Diagnostics Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Next Generation Cancer Diagnostics Market Size (2015-2026)
13.2 Oceania Next Generation Cancer Diagnostics Key Players in North America (2015-2020)
13.3 Oceania Next Generation Cancer Diagnostics Market Size by Type (2015-2020)
13.4 Oceania Next Generation Cancer Diagnostics Market Size by Application (2015-2020)
14. South America
14.1 South America Next Generation Cancer Diagnostics Market Size (2015-2026)
14.2 South America Next Generation Cancer Diagnostics Key Players in North America (2015-2020)
14.3 South America Next Generation Cancer Diagnostics Market Size by Type (2015-2020)
14.4 South America Next Generation Cancer Diagnostics Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Next Generation Cancer Diagnostics Market Size (2015-2026)
15.2 Rest of the World Next Generation Cancer Diagnostics Key Players in North America (2015-2020)
15.3 Rest of the World Next Generation Cancer Diagnostics Market Size by Type (2015-2020)
15.4 Rest of the World Next Generation Cancer Diagnostics Market Size by Application (2015-2020)
16 Next Generation Cancer Diagnostics Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
